Tianlong products have made important contributions in hepatitis, AIDS, hand, foot and mouth disease, avian influenza, eugenics, food safety testing, and sudden public health incidents have been widely concerned by leaders at all levels. In 2009, Tianlong Fluorescent Quantitative PCR instrument inspected the first case of H1N1 in Shaanxi; 2012 Handheld ATP fluorescent detector thousands of Chinese standard food safety departments; 2013 people infected H7N9 avian influenza prevention and control period, Tianlong fluorescent Quantitative PCR and nucleic acid extractors and reagents are equipped with a number of provincial and land-level CDCs, hospitals such as Zhejiang University, Hubei, Jiangsu, Beijing, etc., and completed thousands of suspected flu samples. Viral nucleic acid extraction and screening, CCTV News Network and the official website of the Ministry of Science and Technology conducted special reports; 2013 fluorescent quantitative PCR instruments were broughturs in large quantities of medical and CDC systems in multiple provinces.Tianlong products apply for more than 20 intellectual property rights such as invention patents, and obtain six provincial and ministerial level science and technology awards. The results are selected in \"National Eleventh Five-Year Major Science and Technology Achievement Exhibition \", \"Twelfth Five-Year Technology Innovation Achievement Exhibition \" Deputy Prime Minister Liu Yandong, Wan Steel Minister, Deputy Minister of Hou Jianguo, etc.In 2014, the West Afbola epidemic, Tianlong Technology utilizes inventive patents such as hypersensitive molecular diagnosis and other inventions, and rapid response to the development and production of Ebola virus nucleic acid detection reagents. The kit passes through the CFDA strict assessment, adopted emergency approval and won national CFDA registration certificates, officially included in my country and West Africa to diagnose Ebola virus and epidemic prevention and control emergency response products. In June 2015, South Korea broke the MRS Syndrome (MERS), Tianlong Technology took the lead in developing successful MERS testing reagents and exported to South Korea, sent to many provincial CDCs and hospitals in China, used for national flu monitoring network, fixed hospital The initial screening of influenza, fever patients, etc. In June 2016, Liu Yandong, member of the Political Bureau of the Central Committee and Vice Premier of the State Council, in Jiangsu survived national innovation, driving development strategy and people's livelihood reform, company founders, and national science and technology innovation entrepreneurial talents Peng Jiancai talents conducted product function demonstration, and reported work. In 2017, Tianlong Fluorescence Quantitative PCR instrument and reagent detected the first case of H7N9 people in Shaanxi. We have a dream of creating healthy life with science and technology, helping my country's public health epidemic prevention and control!
